Healthera
Total Raised
$7.17MInvestors Count
11Deal Terms
1Funding, Valuation & Revenue
8 Fundings
Healthera has raised $7.17M over 8 rounds.
Healthera's latest funding round was a Series A - II for $2.66M on April 16, 2025.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
4/16/2025 | Series A - II | $2.66M | 2 | |||
7/1/2023 | Convertible Note - III | |||||
12/1/2022 | Loan | |||||
7/7/2022 | Convertible Note - II | |||||
8/16/2018 | Series A |
Date | 4/16/2025 | 7/1/2023 | 12/1/2022 | 7/7/2022 | 8/16/2018 |
|---|---|---|---|---|---|
Round | Series A - II | Convertible Note - III | Loan | Convertible Note - II | Series A |
Amount | $2.66M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 |
Healthera Deal Terms
1 Deal Term
Healthera's deal structure is available for 1 funding round, including their Series A from August 16, 2018.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Healthera Investors
11 Investors
Healthera has 11 investors. Committed Capital invested in Healthera's Series A - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/16/2025 | 4/16/2025 | 1 Series A - II | Private Equity | United Kingdom | ||
7/7/2022 | 7/1/2023 | 2 Convertible Note - II, Convertible Note - III (2023) | Venture Capital | Canada | ||
12/1/2022 | 12/1/2022 | 1 Loan | Government | United Kingdom | ||
Venture Capital | United Kingdom | |||||
Corporation | United Kingdom |
First funding | 4/16/2025 | 7/7/2022 | 12/1/2022 | ||
|---|---|---|---|---|---|
Last Funding | 4/16/2025 | 7/1/2023 | 12/1/2022 | ||
Investor | |||||
Rounds | 1 Series A - II | 2 Convertible Note - II, Convertible Note - III (2023) | 1 Loan | ||
Board Seats | |||||
Type | Private Equity | Venture Capital | Government | Venture Capital | Corporation |
Location | United Kingdom | Canada | United Kingdom | United Kingdom | United Kingdom |
Compare Healthera to Competitors
BeWell is a company focused on healthcare technology, specifically within the pharmacy sector. The company provides an interoperable platform for pharmacies, which aids in patient engagement, operational improvement, and the delivery of care. This platform includes features such as a pharmacy console for patient data management, a scheduling service, and a patient application for communication and medication ordering. It was founded in 2000 and is based in Amersham, England.
BE WELL helps hospitals reduce costs and optimize time with artificial intelligence. The company was founded in 2021 and is based in Vitória, Brazil.
Charac operates as a pharmacy tech platform focusing on digitally empowering independent community pharmacies. The company offers a suite of tools that facilitate prescription management, patient consultations, prescription delivery, and marketing support for pharmacies. Its platform primarily serves the pharmacy sector, it also provides benefits to patients by improving access to healthcare services. It was founded in 2020 and is based in Kent, United Kingdom.
HubRx is a company focused on transforming community pharmacy through the development of the UK’s first state-of-the-art centralised automated pharmacy for independent pharmacy contractors. The company offers an automated prescription assembly service designed to increase efficiency and enable pharmacies to concentrate on providing higher value clinical services. HubRx primarily serves the independent pharmacy sector, offering solutions to re-engineer their processes and expand their clinical services. It was founded in 2020 and is based in Leeds, England.
Accessa is a manager of a new generation of patient support programs within the healthcare sector. The company focuses on providing accessible, effective, and ethical support programs to facilitate the management of specialty medication prescriptions for individuals with chronic or rare diseases. Accessa primarily serves the healthcare industry, particularly in the realm of pharmaceutical care and patient support. It is based in Montreal, Quebec.
Qwark is a digital pharmacy platform that operates within the healthcare sector, focusing on improving the pharmacy experience for patients. The company offers an AI pharmacy assistant, online prescription management, and medication delivery services for both insured and uninsured individuals. Qwark also integrates telehealth services and provides virtual consultations and medication price comparisons. It was founded in 2020 and is based in Glen Allen, Virginia.
Loading...